SCHEMBL516178

SCHEMBL516178

CCC(O)Oc1ccccc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.49
KDM4E B2RXH2 3/20 0.49
ALOX15 P16050 2/20 0.45
KMT2A Q03164 5/20 0.42
CYP3A4 P08684 4/20 0.42
CYP2D6 P10635 4/20 0.42
SLC6A2 P23975 3/20 0.42
LMNA P02545 3/20 0.42
MEN1 O00255 3/20 0.42
CHRM1 P11229 2/20 0.42
TSHR P16473 2/20 0.42
ADRA2B P18089 2/20 0.42
HTR2A P28223 2/20 0.42
HTR2C P28335 2/20 0.42
SLC6A4 P31645 2/20 0.42
HRH1 P35367 2/20 0.42
OPRM1 P35372 2/20 0.42
DRD3 P35462 2/20 0.42
OPRK1 P41145 2/20 0.42
HTR2B P41595 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7120232 0.84 CYP1A2 (0.58) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL9037772 0.82 CYP1A2 (0.47) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL10359832 0.82 CYP1A2 (0.47) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL13696499 0.81 NISCH (0.49) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL2349413 0.80 TSHR (0.48) KDM4EALOX15CYP3A4LMNATSHR
SCHEMBL27925565 0.79 CYP1A2 (0.45) CYP1A2KDM4EALOX15KMT2ACYP3A4
SCHEMBL11253519 0.78 L3MBTL1 (0.46) CYP1A2KDM4ECYP3A4CYP2D6SLC6A2
SCHEMBL8717379 0.78 ALDH1A1 (0.37) ALOX15LMNADRD3ADRB2ADRB1
SCHEMBL11053775 0.78 ALDH1A1 (0.46) CYP1A2KMT2ASLC6A2LMNAMEN1
SCHEMBL16241822 0.78 KMT2A (0.43) CYP1A2KMT2ALMNAMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111465589-B Compound having fluorene skeleton and method for producing same 帝人株式会社 2024-01-05 CN disclosed
US-11339249-B2 Compound having fluorene skeleton, and method for manufacturing same TEIJIN LIMITED (JP) 2022-05-24 US disclosed
EP-3747856-A1 COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME Teijin Limited (JP) 2020-12-09 EP disclosed
US-20200354517-A1 COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME TEIJIN LIMITED (JP) 2020-11-12 US disclosed
CN-111465589-A Compound having fluorene skeleton and method for producing same 帝人株式会社 2020-07-28 CN disclosed
WO-2020085222-A1 CRYSTAL OF COMPOUND HAVING FLUORENE SKELETON AND METHOD FOR PRODUCING SAME 帝人株式会社 2020-04-30 WO disclosed
WO-2019151264-A1 COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME 帝人株式会社 2019-08-08 WO disclosed
US-8841491-B2 Method for producing fluorene derivative TAOKA CHEMICAL CO., LTD. (JP) 2014-09-23 US disclosed
EP-2420485-A1 METHOD FOR PRODUCING FLUORENE DERIVATIVE Taoka Chemical Co., Ltd. (JP) 2012-02-22 EP disclosed
US-20120029244-A1 METHOD FOR PRODUCING FLUORENE DERIVATIVE TAOKA CHEMICAL CO., LTD. (JP) 2012-02-02 US disclosed
EP-0391942-A1 PROCESS FOR THE PREPARATION OF ARYLOXYACETIC ACID EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1990-10-17 EP disclosed
US-4935540-A OXIDIZING ARYLOXYETHANOL IN PRESENCE OF PALLADIUM AND THALLIU M ON CARBON CATALYST, ACIDIFYING EASTMAN CHEMICAL COMPANY 1990-06-19 US disclosed
WO-1989003378-A1 PROCESS FOR THE PREPARATION OF ARYLOXYACETIC ACID EASTMAN KODAK COMPANY (US) 1989-04-20 WO disclosed
US-4804777-A OXIDATION OF ARYLOXYETHANOL USING PALLADIUM, SILVER, CARBON CATALYST EASTMAN KODAK COMPANY (US) 1989-02-14 US disclosed
EP-0018947-B1 DYEING COMPOSITION AND PROCESSES FOR DYEING FABRICS MADE OF POLYESTER OR A POLYESTER BLEND WITH COTTON OR WOOL CIBA-GEIGY AG (CH) 1984-02-01 EP disclosed
US-4311480-A Dyeing composition CIBA-GEIGY CORPORATION (US) 1982-01-19 US disclosed
EP-0011793-B1 PROCESS FOR PREPARING ARYLOXYACETIC ACIDS BAYER AG (DE) 1981-09-02 EP disclosed
US-4238625-A ACTIVATORS OF LEAD AND/OR BISMUTH AND/OR THEIR COMPOUNDS FOR OXIDATION WITH PLATINUM OR PALLADIUM CATALYST BAYER AKTIENGESELLSCHAFT (DE) 1980-12-09 US disclosed
EP-0018947-A2 Dyeing composition and processes for dyeing fabrics made of polyester or a polyester blend with cotton or wool CIBA-GEIGY AG (CH) 1980-11-12 EP disclosed
EP-0011793-A1 Process for preparing aryloxyacetic acids BAYER AG (DE) 1980-06-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200354517-A1 COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME RFT1, AFF1, RER1 CYP1A2 382/4885KDM4E 2520/4885ALOX15 1522/4885
US-20120029244-A1 METHOD FOR PRODUCING FLUORENE DERIVATIVE ADH1A, AFF2, AFF1 CYP1A2 15/4885KDM4E 2364/4885ALOX15 1242/4885
US-11339249-B2 Compound having fluorene skeleton, and method for manufacturing same RFT1, AFF1, RER1 CYP1A2 382/4885KDM4E 2520/4885ALOX15 1522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.